C12N 2501/235
Leukemia inhibitory factor [lif]
Official title: Leukemia inhibitory factor [LIF]
C12N2501/235 (Leukemia inhibitory factor [lif]) appears on 322 US grants and 605 published applications in this corpus.
Search patents in C12N- Granted patents
- 322
- Published applications
- 605
- Assignees
- 325
- Inventors
- 1,001
- Latest grant
- 8 Sep 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1992 | 1 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 3 | 0 |
| 1996 | 1 | 0 |
| 1997 | 6 | 0 |
| 1998 | 4 | 0 |
| 1999 | 10 | 0 |
| 2000 | 12 | 0 |
| 2001 | 8 | 2 |
| 2002 | 6 | 14 |
| 2003 | 6 | 33 |
| 2004 | 4 | 20 |
| 2005 | 3 | 35 |
| 2006 | 10 | 29 |
| 2007 | 6 | 26 |
| 2008 | 9 | 30 |
| 2009 | 12 | 29 |
| 2010 | 16 | 33 |
| 2011 | 7 | 20 |
| 2012 | 14 | 33 |
| 2013 | 9 | 28 |
| 2014 | 17 | 23 |
| 2015 | 27 | 19 |
| 2016 | 17 | 28 |
| 2017 | 15 | 24 |
| 2018 | 14 | 24 |
| 2019 | 11 | 18 |
| 2020 | 17 | 14 |
| 2021 | 15 | 28 |
| 2022 | 4 | 22 |
| 2023 | 9 | 15 |
| 2024 | 10 | 29 |
| 2025 | 8 | 18 |
| 2026 | 10 | 11 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- Radial glia and astrocyte differentiation from human pluripotent stem cells8 Sep 2026US 12,729,367 B2The United States of America, as represented by the Secretary, Department of Health and Human Services
- Generating populations of human blood and blood vessel progenitors from pluripotent stem cells14 Jul 2026US 12,680,077 B2The Board of Trustees of the Leland Stanford Junior University
- Media for culturing naive human pluripotent stem cells14 Jul 2026US 12,680,083 B2Yeda Research and Development Co. Ltd.
- Reprogramming methods and cell culture platforms5 May 2026US 12,618,049 B2Fate Therapeutics, Inc.
- Method for producing oligodendrocyte-like cells24 Mar 2026US 12,584,106 B2Jsr Corporation
- Reprogramming methods and cell culture platforms1 Oct 2026US 2026/0297537 A1Fate Therapeutics, Inc.
- Radial Glia and Astrocyte Differentiation from Human Pluripotent Stem Cells24 Sep 2026US 2026/0286296 A1The United States of America, as represented by the Secretary, Dept. of Heath and Human Services
- Method for producing primed pluripotent stem cells27 Aug 2026US 2026/0250631 A1Kyoto University
- Photoreceptors and photoreceptor progenitors produced from pluripotent stem cells16 Jul 2026US 2026/0199398 A1Astellas Institute for Regenerative Medicine
- Two-dimensional processes for the expansion of tumor infiltrating lymphocytes and therapies therefrom9 Jul 2026US 2026/0193606 A1Iovance Biotherapeutics, Inc.
Most cited
By later US patents
- Pluripotential embryonic stem cells and methods of making same205US 5,453,357 AVanderbilt University · 1995
- Method for generating an animal homozygous for a genetic modification199US 7,294,754 B2Regeneron Pharmaceuticals, Inc. · 2007
- Human CNS neural stem cells194US 5,968,829 ACytoTherapeutics, Inc. · 1999
- Human embryonic pluripotent germ cells172US 6,090,622 AJohns Hopkins School of Medicine · 2000
- Multiponent adult stem cells and methods for isolation161US 7,015,037 B1M.C.L. Co., Ltd. · 2006